OTC Markets OTCQB - Delayed Quote USD

NUREXONE BIOLOGIC INC (NRXBF)

0.4826
-0.0069
(-1.41%)
At close: June 12 at 8:00:00 PM EDT

Valuation Measures

Annual Monthly
Currency in USD Download
Current3/31/202512/31/20249/30/20246/30/20243/31/2024
Market Cap 36.71M 33.27M 30.70M 29.75M 32.33M 36.85M
Enterprise Value 36.16M 30.78M 28.21M 27.39M 29.10M 35.71M
Trailing P/E -- -- -- -- -- --
Forward P/E -- -- -- -- -- --
PEG Ratio (5yr expected) -- -- -- -- -- --
Price/Sales -- -- -- -- -- --
Price/Book 28.61 11.81 10.44 11.23 9.46 50.49
Enterprise Value/Revenue -- -- -- -- -- --
Enterprise Value/EBITDA -- -- -- -- -- --
3/31/2024 - 11/10/2023

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 12/31/2024
Most Recent Quarter (mrq) 3/31/2025

Profitability

Profit Margin 0.00%
Operating Margin (ttm) 0.00%

Management Effectiveness

Return on Assets (ttm) -115.19%
Return on Equity (ttm) -234.44%

Income Statement

Revenue (ttm) --
Revenue Per Share (ttm) --
Quarterly Revenue Growth (yoy) --
Gross Profit (ttm) --
EBITDA -5.7M
Net Income Avi to Common (ttm) -5.8M
Diluted EPS (ttm) -0.0800
Quarterly Earnings Growth (yoy) --

Balance Sheet

Total Cash (mrq) 588k
Total Cash Per Share (mrq) 0.01
Total Debt (mrq) 31k
Total Debt/Equity (mrq) 2.36%
Current Ratio (mrq) 2.47
Book Value Per Share (mrq) 0.02

Cash Flow Statement

Operating Cash Flow (ttm) -4.41M
Levered Free Cash Flow (ttm) -2.93M

Trading Information

Stock Price History

Beta (5Y Monthly) -0.03
52 Week Change 3 14.36%
S&P 500 52-Week Change 3 9.20%
52 Week High 3 0.6075
52 Week Low 3 0.3776
50-Day Moving Average 3 0.4945
200-Day Moving Average 3 0.4633

Share Statistics

Avg Vol (3 month) 3 9.77k
Avg Vol (10 day) 3 45.92k
Shares Outstanding 5 78.01M
Implied Shares Outstanding 6 78.05M
Float 8 73.29M
% Held by Insiders 1 5.35%
% Held by Institutions 1 0.00%
Shares Short 4 --
Short Ratio 4 --
Short % of Float 4 --
Short % of Shares Outstanding 4 --
Shares Short (prior month ) 4 --

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 --
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 0.00%
Dividend Date 3 --
Ex-Dividend Date 4 --
Last Split Factor 2 --
Last Split Date 3 --

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq = Most Recent Quarter
  • ttm = Trailing Twelve Months
  • yoy = Year Over Year
  • lfy = Last Fiscal Year
  • fye = Fiscal Year Ending

Related Tickers